Management of the small renal mass: what is the most reasonable option?

References

• Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA281, 1628–1631 (1999).
   PubMed Web of Science ®Google Scholar
• Katz DL, Zheng T, Holford TR, Flannery J. Time trends in the incidence of renal carcinoma: analysis of Connecticut Tumor Registry data, 1935–1989. Int. J. Cancer58, 57–63 (1994).
   PubMedGoogle Scholar
• AUA Clinical Guidelines. Guideline for management of the clinical stage 1 renal mass. 1–76 (2009).
   Google Scholar
• Kunkle DA, Crispen PL, Chen DY, Greenberg RE, Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. J. Urol.177, 849–853 (2007).
   PubMed Web of Science ®Google Scholar
• Kouba E, Smith A, McRackan D, Wallen EM, Pruthi RS. Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J. Urol.177, 466–470 (2007).
   PubMed Web of Science ®Google Scholar
• Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY. Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J. Urol.175, 425–431 (2006).
   PubMed Web of Science ®Google Scholar
• Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DYT, Uzzo RG. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer115(13), 2844–2852 (2009).
   PubMedGoogle Scholar
• Kato M, Suzuki T, Suzuki Y, Terasawa Y, Sasano, Arai Y. Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J. Urol.172(3), 863–866 (2004).
   PubMed Web of Science ®Google Scholar
• Volpe A, Kachura JR, Geddie WR et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J. Urol.178(2), 379–386 (2007).
   PubMed Web of Science ®Google Scholar
• Shannon BA, Cohen RJ, de Bruto H, Davies RJ. The value of preoperative needle core biopsy for diagnosis of benign lesions among small, incidentally detected renal masses. J. Urol.180(4), 1257–1261 (2008).
   PubMed Web of Science ®Google Scholar
• Rybicki FJ, Shu KM, Cibas ES, Fielding JR, van Sonnenberg E, Silverman SG. Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am. J. Roentgenol.180(5), 1281–1287 (2003).
   PubMedGoogle Scholar
• Schmidbauer J, Remzi M, Memarsadeghi M et al. Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur. Urol.53(5), 1003–1011 (2008).
   PubMed Web of Science ®Google Scholar
• Kume H, Suzuki M, Fujimura T et al. Distant metastasis of renal cell carcinoma with a diameter of 3 cm or less-which is aggressive cancer? J. Urol.184(1), 64–68 (2010).
   PubMedGoogle Scholar
• Mason RJ, Abdolell M, Trottier G et al. Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance. Eur. Urol.59(5), 863–867 (2011).
   PubMed Web of Science ®Google Scholar
• Huang WC, Levey AS, Serio AM et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumors: a retrospective cohort study. Lancet Oncol.7(9), 735–740 (2006).
   PubMed Web of Science ®Google Scholar
• Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J. Urol.163(2), 442–445 (2000).
   PubMed Web of Science ®Google Scholar
• Lau WK, Blute ML, Weaver AL, Torres VE. Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin. Proc.75(12), 1236–1242 (2000).
   PubMed Web of Science ®Google Scholar
• Permpongkosol S, Bagga HS, Romero FR, Sroka M, Jarrett TW, Kavoussi LR. Laparoscopic versus open patrial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate. J. Urol.176(5), 1984–1988 (2006).
   PubMed Web of Science ®Google Scholar
• Lane BR, Gill IS. 7-year oncological outcomes after laparoscopic and open partial nephrectomy. J. Urol.183(2), 473–479 (2010).
   PubMed Web of Science ®Google Scholar
• Abouassaly R, Alibhai SM, Tomlinson G, Timilshina N, Finelli A. Unintended consequences of laparoscopic surgery on partial nephrectomy for kidney cancer. J. Urol.183(2), 467–472 (2010).
   PubMed Web of Science ®Google Scholar
• Aron M, Koenig P, Kaouk JH et al. Robotic and laparoscopic partial nephrectomy: a matched-pair comparison from a high-volume centre. BJU Int.102, 86 (2008).
   PubMed Web of Science ®Google Scholar
• Caruso RP, Philips CK, Kau E, Taneja SS, Stifelman MD. Robot assisted laparoscopic partial nephrectomy: initial experience. J. Urol.176(1), 36–39 (2006).
   PubMed Web of Science ®Google Scholar
• Benway BM, Bhayani SB, Rogers CG et al. Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes. J. Urol.182(3), 866–873 (2009).
   PubMed Web of Science ®Google Scholar
• Zagoria RJ, Pettus JA, Rogers M, Werle DM, Childs D, Leyendecker JR. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology77(6), 1393–1397 (2011).
   PubMed Web of Science ®Google Scholar
• Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer116(13), 3135–3142 (2010).
   PubMed Web of Science ®Google Scholar
• Leveridge MJ, Mattar K, Kachura J, Jewett MA. Assessing outcomes in probe ablative therapies for small renal masses. J. Endourol.24(5), 759–764 (2010).
   PubMed Web of Science ®Google Scholar